Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Introduction: Understanding the experiences of women participating in residential alcohol and other drug (AOD) treatment is important in ensuring treatment effectively meets women's needs. Patient-reported experience measures aid in assessing women's experiences of treatment but are often used to quantify women's treatment satisfaction without additional context regarding specific treatment experiences. This study examined the relationship between the domains of the Patient Reported Experience Measure for Addiction Treatment (PREMAT) and overall treatment satisfaction, including whether relationships differed by gender.
Methods: N = 138 participants (30.9% women) from a not-for-profit residential AOD treatment service completed a survey regarding their experiences of and satisfaction with treatment, including the PREMAT. Descriptives, chi-square and Mann-Whitney U statistics examined gender differences in demographics. A generalised linear model assessed the relationship between PREMAT domain scores and overall treatment satisfaction (Client Satisfaction Questionnaire), controlling for age and weeks in treatment, including whether relationships differed by gender. Relative weight statistics examined the relative statistical importance of each PREMAT domain to overall satisfaction.
Results: There were no gender differences on PREMAT item, domain or total scores. Controlling for age and weeks in treatment, significant predictors of overall treatment satisfaction were the PREMAT 'self-determination and empowerment' and 'personal responsibility' domains. The impact of 'personal responsibility' on overall satisfaction was weaker for women compared to men.
Discussion And Conclusions: Fostering individualised care and support, self-determination, empowerment and personal responsibility for care, are important aspects of residential treatment for both men and women. Further development of women-specific PREMs that address gendered experiences of treatment is warranted.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12405812 | PMC |
| http://dx.doi.org/10.1111/dar.70011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Metastatic Breast Cancer mHealth App to Promote Patient-Provider Communication: Protocol for a Usability and Satisfaction Study.
JMIR Res Protoc
September 2025
Department of Health Services Research & Administration, College of Public Health, University of Nebraska Medical Center, Omaha, NE, United States.
Background: With the availability of more advanced and effective treatments, life expectancy has improved among patients with metastatic breast cancer (MBC), but this makes communication with their medical oncologist more complex. Some patients struggle to learn about their therapeutic options and to understand and articulate their preferences. Mobile health (mHealth) apps can enhance patient-provider communication, playing a crucial role in the diagnosis, treatment, quality of life, and outcomes for patients living with MBC.
View Article and Find Full Text PDFBackground: People with opioid use disorder (OUD) often exhibit high rates of nonprescribed drug use and low retention on buprenorphine. This study tested the feasibility, acceptability, and preliminary efficacy of an intervention combining peer recovery coaching and CBT4CBT-buprenorphine (CBT4CBT+RC) to reduce nonprescribed drug use and increase buprenorphine retention.
Methods: A randomized trial conducted from December 15, 2020, to November 24, 2021, compared an 8-week CBT4CBT+RC intervention to treatment as usual (TAU).
Donor site healing in follicular unit extraction hair transplantation: current evidence, cellular mechanisms, and future research directions.
Cell Mol Biol (Noisy-le-grand)
September 2025
Arencibia Clinic, San Sebastian, Spain.
Follicular unit extraction (FUE) has become a leading technique in hair transplantation, yet optimal management of the donor area remains a clinical challenge. This systematic review analyzes intraoperative and postoperative interventions applied to the donor area in FUE hair transplantation, with a focus on both clinical outcomes and the cellular and molecular mechanisms involved in tissue repair, inflammatory response, and regenerative processes. A comprehensive literature search was conducted in PubMed and EMBASE (January 2000-June 2025), identifying clinical studies that evaluated donor area treatments and reported outcomes related to healing, inflammation, infection, and patient satisfaction.
View Article and Find Full Text PDFOpioid agonist therapy for opioid use disorder in primary versus specialty care.
Cochrane Database Syst Rev
September 2025
Department of Family Medicine, University of Alberta, Edmonton, Alberta, Canada.
Background: Opioid use disorder (OUD) is commonly treated in specialized care settings with long-acting opioid agonists, also known as opioid agonist therapy, or OAT. Despite the rise in opioid use globally and evidence for a 50% reduction in mortality when OAT is employed, the proportion of people with OUD receiving OAT remains small. One initiative to improve the access and uptake of OAT could be to offer OAT in a primary care setting; primary care clinics are more numerous, might reduce the visibility and potential stigma of receiving treatment for OUD, and may facilitate the care of other medical conditions that are unrelated to OUD.
View Article and Find Full Text PDFManagement of Severe Ulcerative Colitis with Ambulatory Intravenous Corticosteroids (MOSAIC): A Treatment Approach to Avoid Hospitalization in Immunocompromised Patients.
Crohns Colitis 360
July 2025
Division of Gastroenterology, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.
Introduction: Acute severe ulcerative colitis (ASUC) typically requires hospitalization for intravenous (IV) corticosteroid treatment and monitoring. In response to the need to reduce inpatient stays, especially during the COVID-19 pandemic, outpatient treatment models have gained interest. This study evaluated the feasibility, safety, and patient satisfaction of outpatient IV corticosteroid treatment for ASUC.
View Article and Find Full Text PDF